INTRODUCTION
Regulatory T cells (Tregs) play critical roles in the maintenance of immune homeostasis and prevention of autoimmunity and inflammation. 1 Tregs were initially described by Gershon and Kondo in the early 1970s and were called suppressive T cells. 2, 3 In 1995, Sakaguchi et al. demonstrated that the interleukin-2 (IL-2) receptor a-chain, CD25, served as a phenotypic marker for CD4 1 suppressor T cells or CD4 1 Tregs and that these CD25 1 CD4 1 T cells prevented the development of autoimmune diseases. 4 Since then, many phenotypically distinct CD4 1 Treg subsets have been identified, including Foxp3 1 , IL-10-secreting Tr1, transforming growth factor (TGF)-b-secreting Th3, and Foxp3 neg iT(R)35 cells. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The mechanisms of Treg function generally include the following: suppression by inhibitory cytokines, such as interleukin-10 (IL-10), TGF-b, and IL-35; suppression of effector T cells by IL-2 depletion or generation of pericellular adenosine; suppression by targeting dendritic cells (DCs) through cytotoxic T lymphocyte-associated antigen (CTLA), indoleamine 2,3-dioxygenase, and lymphocyte-activation gene 3; and cytolysis by secretion of granzyme-A and -B. 15, 16 Vascular endothelial growth factor receptor-1 (VEGFR1) has seven immunoglobulin (Ig)-like domains in the extracellular domain (ECD), a single transmembrane region and a consensus tyrosine kinase sequence. VEGFR1 binds VEGFA, VEGFB, and placental growth factor (PlGF). VEGFR1 was initially reported to act as a decoy receptor and modulates angiogenesis through its ability to sequester VEGFA because of its weak tyrosine kinase activity and a high affinity for VEGFA. 17, 18 Recently, VEGFR1 was shown to mobilize bone marrow-derived cells via its tyrosine kinase activity 19 as well as induce monocyte migration and chemotaxis. 20 , 21 Kaplan et al. demonstrated that VEGFR1
1 hematopoietic bone marrow progenitors home to tumor-specific pre-metastatic sites and dictate organ-specific tumor spread. 22 Dikov et al. reported that VEGFR1 is the primary mediator of VEGF-mediated inhibition of DC maturation. 23 In the case of T cells, the engagement of T-cell VEGFR1 with its ligand induces IL-10 production and chemotaxis toward VEGF. 24 However, the function of VEGFR1-expressing CD4
1 T cells has not been identified. Our previous work prompted us to investigate whether a subset of CD4 1 VEGFR1 high T cells contains suppressive capacity similar to that of Tregs. In this study, we show that CD4
1 VEGFR1 high T cells exist in the lymph node, spleen, and thymus, and they are phenotypically distinct from other known Tregs. Importantly, CD4
1 VEGFR1 high T cells can suppress T-cell proliferation via soluble factor-mediated apoptosis and lead to suppression of effector T-cell-mediated inflammatory colitis, as shown by adoptive transfer into RAG-2-deficient mice. In summary, we report CD4 1 VEGFR1
high T cells as a distinct subset of Tregs that regulate the development of inflammatory bowel disease (IBD).
MATERIALS AND METHODS
Mice GFP-Foxp3 knock-in mice on a C57BL/6 background were generously provided by Prof. Seong-Hoe Park (Seoul National University college of Medicine) with the permission of Prof. A. Rudensky (Memorial Sloan-Kettering Cancer Center). Thy1.1-B6 and RAG-2 knock-out (KO) mice were purchased from The Jackson Laboratory. OT-II mice were provided by Prof. Dong Sup Lee (Seoul National University College of Medicine). C57BL/6 mice at 7-12 weeks of age were purchased from Central Laboratory Animal, Inc. and maintained in specific pathogen-free conditions, according to the guidelines of the Institute of Laboratory Animal Resources of Seoul National University. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Seoul National University.
Flow cytometry
Single-cell suspensions of thymi, lymph nodes (inguinal, axial), and spleens from 7-to 10-week-old mice were washed and resuspended in 100 mL of cold staining buffer (0.5% bovine serum albumin (BSA) and 0.1% sodium azide in phosphate-buffered saline (PBS), Sigma-Aldrich, St. Louis, MO, USA). Before staining, each sample was blocked with anti-FcR monoclonal antibodies (mAbs) (2.4G2, American Type Culture Collection, Rockville, MD, USA) for 10 min at room temperature (RT). The following antibodies (Abs) were used: FITC-or PE-labeled anti-CD8a, APC-Cy7-labeled anti-CD25, PerCP or PE-labeled anti-CD3, FITC-labeled anti-CD103, PE-labeled anti-CTLA4 (for cell surface), and the respective isotype control Abs (BD Biosciences, San Jose, CA, USA). APC-labeled or purified anti-mouse VEGFR1 Abs were from R&D Systems (Minneapolis, MN, USA). FITCor PE-Cy7 labeled anti-CD4, FITC-labeled anti-GITR, and the respective isotype control Abs were from eBioscience (San Diego, CA, USA). Alexa Fluor 647-labeled anti-rat IgG was from Invitrogen (Eugene, OR, USA). The cells were incubated for 30 min on ice in 100 mL of staining buffer containing the appropriate concentration of Ab. At the end of the staining, the pellets were washed with staining buffer and analyzed using a FACSCanto flow cytometer (BD Biosciences). The data were analyzed using BD FACSDiva and FlowJo software. For detection of intracellular (IC) cytokine production, the cultured CD4 1 T cells were restimulated with 50 ng mL 21 phorbol 12-myristate 13-acetate (PMA) plus 500 ng mL 21 ionomycin plus Brefeldin A (10 mg mL
21
) for 5 h. The cells were stained with APC-labeled anti-mouse interferonc (IFN-c) and PE-labeled anti-mouse IL-17A (BD Biosciences) using IC fixation buffer and 103 permeabilization buffer (eBioscience). IC staining of Foxp3 was conducted using FITClabeled anti-mouse Foxp3 (FJK-16s), Fixation/Permeabilization Concentrate & Diluent set and 103 permeabilization buffer (eBioscience), according to the manufacturer's instructions.
Isolation of splenic CD4
1 T cells and cell sorting CD4 1 T cells were isolated from the spleens of mice by positive or negative selection using the MACS magnetic separation system (Miltenyi Biotec, Auburn, CA, USA), according to the manufacturer's instructions. Briefly, spleen cell suspensions were incubated in cold protein extraction buffer (PEB) (PBS supplemented with 2 mM ethylenediamine tetraacetic acid (EDTA) and 0.5% BSA) with magnetic microbeads conjugated to anti-CD90.2, anti-mouse CD4, or biotin-Ab cocktail/anti-biotin microbeads (CD4 1 T-cell isolation kit) according to the manufacturer's instructions. The cells were washed twice and loaded onto the magnetic separation columns. Flow cytometry was performed using anti-mouse CD3 or anti-mouse CD4 Abs (eBioscience), and populations were confirmed to be o85% CD3 
Flow cytometric measurement of apoptosis
To assay for apoptosis, cells were harvested, washed with cold PEB, and resuspended in 100 mL of Annexin V staining buffer. PE-Annexin V and 7AAD (BD Biosciences) were added and incubated for 15 min at RT in the dark. After staining, 400 mL of binding buffer was added to each sample. The results were analyzed by flow cytometry. To determine the mechanism of apoptosis induction, we investigated B-cell lymphoma 2 (Bcl-2) expression (intrinsic pathway) and caspase-8 activity (extrinsic pathway). For IC detection of Bcl-2, the cells were harvested, washed in cold PEB, fixed with 100 mL of IC fixation buffer (eBioscience), and incubated in the dark at RT for 20 min. After fixation, the cells were washed with permeabilization buffer (eBioscience), stained with FITC-labeled anti-Bcl-2 (eBioscience), incubated in the dark at RT for 20 min, washed with permeabilization buffer, and analyzed by flow cytometry. IC caspase-8 detection was performed using the caspase-8 apoptosis detection kit (Santa Cruz Biotechnology, Santa Cruz, CA, USA), according to the manufacturer's instructions. Briefly, the cells were harvested and washed with PBS, and reaction mixtures were prepared by combining 100 mL of cell suspension, 400 mL of PBS, and 10 mL of N-Acetyl-Ile-GluThr-Asp-7-amino-4-(trifluoromethyl)-coumarin (IETD-AFC) substrate. The reaction mixtures were incubated for 1 h at 37 uC, and free AFC was measured by flow cytometry. The results are presented as the amount of AFC from apoptotic cells to that of non-apoptotic cells.
Adoptive T-cell transfer to RAG2 KO mice and cell preparations
1 T cells were sorted using a BD-FACS Aria I cell sorter (BD Biosciences) and intravenously transferred into seven-week-old RAG2 KO mice. After seven weeks, the recipient mice were sacrificed, and their colon tissues were extracted for histopathological analysis of paraffin-embedded sections stained with hematoxylin and eosin (H&E). Additionally, the body weights of the recipient mice were monitored after T-cell transfer. For cell isolation from peripheral lymphoid organs, the spleens and mesenteric lymph nodes (mLN) were mechanically disrupted into single cell suspensions. To assess for colonic lamina propria lymphocytes (LPL), the colons were isolated and flushed extensively to eliminate the lumen content. The colons were cut into small pieces and incubated in Caand Mg-free PBS-ontaining 10% heat-inactivated fetal bovine serum (FBS), 5 mM EDTA, and 2 mM dithiothreitol (DTT) for 30 min at RT to release intraepithelial lymphocytes. The samples were then resuspended in DMEM with 5% heat-inactivated FBS, 100 U mL 21 collagenase IV (Invitrogen) and 100 mg mL 21 DNase I (Roche Diagnostics, Mannheim, Germany) and shaken at 37 uC for 90 min. The supernatants and colons were collected and passed through a 40-mm strainer and washed. The cells were centrifuged in a Ficoll gradient (GE Healthcare Life Sciences, Piscataway, NJ, USA) at 600g for 40 min. The lymphocytes were collected from the lymphocyte layer, washed, and used for further experiments.
Statistical analysis
The values for all measurements are presented as the mean 6 SEM. Analysis of variance was used to compare the differences between groups. Comparisons for all pairs were performed by Student's t-test. A p-value of 0.05 was considered significant.
RESULTS

Phenotypic analysis of CD4
1 VEGFR1 1 T cells We previously reported that VEGFR1 is expressed on T cells. 24 In that study, goat anti-mouse VEGFR1 polyclonal Ab was used to stain the VEGFR1 on T cells as the mAb was not available at that time. Recently, rat anti-mouse VEGFR1 mAb has been developed and become available. In this study, we reconfirmed the expression of VEGFR1 on T cells by the mAb and found the frequency of VEGFR1 1 T cell was different from that assessed by polyclonal Ab. Approximately 7-15% of CD4
1 and 2-5% of CD8 1 T cells in the spleen, thymus, and lymph nodes expressed VEGFR1 and about 1% of CD4 and CD8 T cells were positive for VEGFR1 in peripheral blood ( Figure 1) . Interestingly, the frequency of VEGFR1
1 cells was higher in double negative (DN, 14%) than in double positive (DP, 5%) thymocytes (histograms shown in Figure 1b) .
For the phenotypic analysis of CD4 1 VEGFR1 1 T cells, we assessed the expression of Foxp3, CD25, glucocorticoid-inducible tumor necrosis factor receptor (GITR), CTLA-4, and CD103 in CD4
1 VEGFR1 1 and CD4
These are specific markers of Tregs. 4, 6, 25, 26 The number of cells expressing CD25, GITR, and CD103 in the CD4 1 VEGFR1 1 Tcell populations was found to be approximately 2-to 3-fold higher than that in the CD4 1 VEGFR1 2 T-cell population (Figure 2b and 2c) . Considering that the number of Foxp3
2 T-cell populations (Figure 2) (Figure 3d ). This result suggested that the suppressive capacity of CD4
1 VEGFR1 high T cell is not dependent on Foxp3.
VEGF and anti-VEGFR1 mAb do not alter CD4 (Figure 4a ) or anti-VEGFR1 mAb (Figure 4b) 1 CD25 2 T cells were labeled with 5 mM CFSE and then stimulated with anti-CD3 and APCs in the presence of CS. As shown in Figure 5b and 5c, the CS from CD4 1 VEGFR1 high T cells significantly inhibited the proliferation of CD4 1 CD25 2 T cells regardless of adding IL-2. Interestingly, the CS from nonstimulated CD4
1 VEGFR1 high T cells slightly suppressed CD4 1 CD25 2 T-cell proliferation (Figure 5d ). These results indicated that most of the suppression of cell proliferation was mediated by soluble factor(s) derived from the activated state of CD4 1 VEGFR1 high T cells. The suppression of cell proliferation and cell death (apoptosis) was determined by CFSE labeling and Annexin V/7AAD, respectively. 29 We stained CD4 1 CD25 2 T cells activated by CS with Annexin V and 7-aminoactinomycin D (7AAD) on day 4 after stimulation and analyzed the cells by flow cytometry. As shown in Figure 6a and 6b, the rate of CD4 1 CD25 2 T cells in all phases of apoptotic death significantly increased, including early apoptosis (Annexin V-positive cells only; Figure 6a , lower right quadrant), late apoptosis (both Annexin V-and 7AAD-positive cells; Figure 6a , upper right quadrant), and necrosis (7AAD-positive cells only; Figure 6a , upper left quadrant). We then assessed the degree of caspase-8 activation and the expression level of Bcl-2, which are known to be representative markers of apoptosis pathways, by Ab staining and subsequent flow cytometric analysis. As shown in Figure 6c , the activity of caspase-8 was significantly higher in the cells treated with CD4
1 VEGFR1 high T-cell-derived CS; however, the expression (Figure 7a) . Histology of the colon revealed the infiltration of inflammatory cells into the lamina propria and submucosa with a thickened wall, which are findings indicative of colitis (Figure 7c) (Figure 7a and 7c) . The spleens and colons of CD4 1 VEGFR1 2 CD25 2 T-cell-transferred RAG2 KO mice were markedly enlarged when compared with that of Treginjected mice (Figure 7b ). The CD4 1 T cells in the lamina propria of the colon of the mice suffering from colitis were isolated and assayed for cytokine expression by IC cytokine staining and fluorescence-activated cell sorting analysis. The percentages of IFN-c 1 CD4 1 T cells in only CD4 1 VEGFR1 2 CD25 2 T-cell-injected mice were 10-fold higher than in control mice, but the ratio of IL-17A-producing CD4 1 cells did not differ between the group of mice with colitis and the control groups (Figure 7d) A novel CD4 1 VEGFR1 high regulatory T-cell subset JY Shin et al VEGF and VEGFR have profound effects on both developmental hematopoiesis and pathologic conditions. 32-38 We first investigated the expression level of VEGFR1 in the murine thymocytes and T cells. We observed DN, DP, and SP (CD4 and CD8) thymocytes expressed VEGFR1. We also observed VEGFR1 on the surface of CD4 and CD8 T cells isolated from spleen and LN, but could find very low levels of VEGFR1 1 cells in T cells from peripheral blood. Of note, we observed the ratio of CD4 and CD8 splenic T cells expressing VEGFR1 varies depending on the nature of Ab (polyclonal vs. monoclonal) resulting in the higher ratio with polyclonal Ab. 24 Considering that VEGFR1 is expressed on human CD34 1 and mouse Lin 2 Sca-1 1 c-Kit 1 hematopoietic stem cells (HSCs), 39 VEGFR1 may be expressed from the early phase of T-cell development, and perhaps these cells be derived from VEGFR1 1 bone marrow HSCs. On the other hand, considering that the frequency of VEGFR1 1 T cells in the peripheral blood is lower than in lymphoid organs, VEGFR1
1 T cells might be induced in certain tissue microenvironment. 
VEGFR1
high or CD4 1 VEGFR1 negative T cells were harvested from different culture conditions. CFSE-labeled (5 mM) CD4 1 CD25 2 T cells (1 3 10 5 ) were stimulated with anti-CD3 (3 mg mL 21 ) and APCs (1 3 10 6 ) and cultured in a medium containing 50% culture supernatants obtained from each culture condition. The supernatants were obtained from cultured CD4
1 VEGFR1 high or CD4
1
VEGFR1
negative T cells (1 3 10 5 ) with plate-bound anti-CD3 (10 mg mL 21 ) and soluble anti-CD28 (1 mg mL 21 ) mAb in the absence (b) or presence (c) of IL-2 (100 U mL
negative T cells were cultured in the absence of stimulators for three days and then each collected supernatant was used as a control (non-conditioned media). Results are shown from one representative experiment out of two performed. Results are shown as mean 6 SEM of triplicates from one representative experiment out of two performed. R1
H and R1 N indicate R1 high and R1 negative , respectively.
A novel CD4 1 VEGFR1 high regulatory T-cell subset
In previous study, we reported that the engagement of VEGFR1 with VEGF did not affect the proliferation of T cells but induced T-cell migration. 24 In mouse model of chronic infusion of VEGF, VEGFR2 signaling significantly inhibited thymic T-cell development and decreased total number of splenic T cells, whereas VEGFR1 signaling contributed to the mobilization of T cells such as T precursors from the bone marrow and T cells from thymus to spleen. 38 Furthermore, the treatment of neutralizing anti-VEGFR1 Ab and exogenous VEGF did not affect the suppressive function of CD4
1
VEGFR1
high T cell. However, VEGFR1 would be involved in the migration of these cells and cause cleavage of IL-2 receptor a (CD25) from the surface of activated T cells through the induction of matrix metalloproteinases (MMPs) under a certain environment such as VEGF or a ligand-enriched environment. 24, 42, 43 Considering these factors that (i) the expression pattern of Foxp3 and several other surface markers in CD4 
high T cell. To get insight into the mechanism that could be responsible for apoptosis induced by CS, we have investigated the impact of extrinsic versus intrinsic apoptosis into CS-induced CD4 1 CD25 2 T-cell death. Apoptosis can be triggered by the ligation of cell surface death receptors (extrinsic apoptosis pathways) or stress signals through the release of apoptogenic factors from mitochondrial intermembrane space (intrinsic apoptosis pathways). 44 Activated caspase-8 is a key molecule that processes downstream effector caspases which subsequently cleave specific substrates resulting in cell death after death receptor ligation in extrinsic apoptosis. Bcl-2 proteins such Bax and Bak cause cytochrome c release from mitochondria, and cytochrome c forms the apoptosome which activates caspase-9 in intrinsic apoptosis. This pathway involves downregulation of Bcl-2 expression. We demonstrated that CS from activated CD4 1 VEGFR1 high T cells highly triggered the activation of 
CD25
2 T cells by CS from CD4 1 VEGFR1 high T cells might be triggered through extracellular (extrinsic) apoptotic pathway including caspase-8 activation. CD95 (APO-1/Fas), tumor necrosis factor (TNF) receptor 1, TNF-related apoptosis-inducing ligand receptor 1(TRAIL-R1) and TRAIL-R2 are the bestcharacterized death receptors as initiators for caspase-8 dependent apoptotic pathway. 45, 46 The corresponding ligands of the TNF superfamily are CD95 ligand (L), TNF-a, lymphotoxin-a, and TRAIL. CD95 L and TRAIL have not only membrane-bound forms but also soluble forms by proteolysis or alternative splicing. 47 In addition, perforin and granzyme B directly cleave caspase-8, which mediates the induction of apoptosis through perf/GrB pathway. 48 We suggest that candidates for apoptosis-mediated soluble factors from CD4 1 VEGFR1 high T cells could be soluble forms of CD95L and TRAIL, perforin, and granzyme B. However, it has reported that CD95L and TRAIL have the severe toxic effect in membrane-forms than in soluble forms. 47 We previously reported that CD4
1 VEGFR1 1 T cells produced IL-10 after VEGF stimulation. 24 Although VEGF signaling has no effect in CD4 1 VEGFR1 high T-cell-mediated suppression (Figure 4) , we wondered if IL-10 could lead to CD4
1
VEGFR1
high T-cell-mediated suppression. As a result, the expression level of IL-10 between activated CD4 1 VEGFR1 high and CD4 
2 CD25 2 and CD4 1 CD25 1 T cells (1:1 ratio) was monitored as a control group. Body weight was monitored as indicated in Figure 6a and is presented as a percentage of initial weight at day 0: (body weight at the indicated days)/(body weight at day 0) 3100 6 SEM. IL-10 could be a possible candidate of soluble factors which inhibit T-cell proliferation but not a major suppressive factor (data not shown). It is also of note that previous studies had reported that unlike neutralizing anti-IL-10 Ab, neutralizing anti-IL-10R Ab could affect the immune-suppressive activities of Tregs, 49, 50 which needs to be further investigated. We also found that the level of TGF-b in the CS of CD4 1 VEGFR1 high T cells was below the detection limit (60 pg mL 21 ). IL-35 is also well-known factors in the mechanism of CD4 1 Foxp3 1 T-cell-mediated suppression. 16, 51 IL-35 is a CD4
1 Foxp3 1 T-cell-specific cytokine that is required for the maximal suppressive capacity in human and mouse, [51] [52] [53] and it is also involved in regulation of mucosal immune responses.
54 CD4 1 VEGFR1 high T cells are not specifically Foxp3-expressing cells. However, the recent study showed that IL-35-mediated negative regulation of immune responses is not restricted to CD4
1 CD25 1 Foxp3 1 T cells. 55 Some papers have reported that microRNA-containing or Fas ligand-expressing exosomes from Tregs or other tissues could mediate effector T-cell apoptosis. [56] [57] [58] Taken together, CD4
1 VEGFR1 high T-cell-mediated suppression might be exerted in various ways depending on the microenvironment, so that further studies to identify soluble factor(s) responsible for the suppressive activity should be considered under various circumstances.
IBD is a chronic and relapsing inflammatory disorder and one of the CD4 1 T-cell-mediated autoimmune diseases. CD4
1
T cells transferred into immune-deficient mice lead to IBD in response to enteric bacterial antigens derived from commensal microorganism, causing lethal weight loss and diarrhea due to endothelial and crypt hyperplasia as well as significant accumulation of lymphocytes, neutrophils, and macrophages within the lamina propria in the large intestine. 31, [59] [60] [61] [62] In most human and mouse cases examined, IBD is associated with Th1-producing TNF and IFN-c, which are important mediators of this disease. 63, 64 Th17 cells also have been suggested to play a key role in the pathogenesis of colitis and IBD, as they convert into Th1 cells and promote Th1 responses through IL-12 and IL-23. 65, 66 We found that adoptive transfer of CD4 1 VEGFR1 2 CD25 2 T cells into RAG2-deficient mice resulted in colitis seven weeks after transfer, whereas the cotransfer of CD4 1 VEGFR1 1 CD25 2 T cells did not induce colitis. The most prominent histopathological changes by CD4
VEGFR1
2 CD25 2 T-cell injection into RAG-2 KO mice were cellular infiltration, absence of crypts, and hypertrophy of all the layers of the colon. These results were consistent with those of previous studies. 60, 62 Therefore, we carefully suggest that understanding of suppressive mechanisms and successful ex vivo expansion of CD4 1 VEGFR1 high T cells could contribute as the therapeutic potential of IBD or chronic inflammatory diseases.
